Cargando…
Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours
BACKGROUND: The vast majority of ovarian mucinous carcinomas are metastatic tumours derived from nonovarian primary cancers, typically gastrointestinal neoplasms. Therapy targeting claudin18.2 might be used in gastric, gastroesophageal junction and pancreatic cancers with high expression of claudin1...
Autores principales: | Wang, Fujun, Yang, Yao, Du, Xiuzhen, Zhu, Xiaoying, Hu, Yanjiao, Lu, Changyu, Sui, Lei, Zhao, Han, Song, Kejuan, Yao, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837907/ https://www.ncbi.nlm.nih.gov/pubmed/36639622 http://dx.doi.org/10.1186/s12885-023-10533-x |
Ejemplares similares
-
A novel algorithm for better distinction of primary mucinous ovarian carcinomas and mucinous carcinomas metastatic to the ovary
por: Simons, Michiel, et al.
Publicado: (2019) -
Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary
por: Lee, Sang won, et al.
Publicado: (2021) -
Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment
por: Wang, Yicong, et al.
Publicado: (2023) -
Recent Insights into Mucinous Ovarian Carcinoma
por: Ricci, Francesca, et al.
Publicado: (2018) -
Therapeutic options for mucinous ovarian carcinoma☆
por: Gorringe, Kylie L., et al.
Publicado: (2020)